In this study, our experimental evidence directly provide that the enhanced IL-6 level of RA patients compared to that of OA can be a switch to turn on the intracellular IL-6 signaling, such as enhanced cytotoxic edema modules NKCC1 and AQP-1 in RA. This evidence concerns the gene SLC12A2 and rheumatoid arthritis.